Here are five points:
1. Two of the patents focus on presacral interbody fusion, specifically two new expandable cages.
2. The expandable cages are intended to create lordosis at L5-S1.
3. The third patent relates to a new technique designed for sacroiliac fusion.
4. TranS1 possesses a portfolio of minimally invasive spine surgery solutions as well as a patent portfolio of spinal health technologies.
5. Over the past three years, the company has received 100-plus issued patents and has 50-plus new patent applications.
More articles on MIS:
Titan Medical reports 2017 full-year financial results: 5 things to know
Saint Anne’s Hospital launches Globus ExcelsiusGPS for minimally invasive spine surgery: 3 insights
7 top device companies in global minimally invasive spine surgery market
